Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ISA 2020

AL Amyloidosis

View all
6:10
Auto-HSCT in AL amyloidosis
Eli Muchtar • 9 Sep 2020
2:20
New prognostic markers in AL amyloidosis
Efstathios Kastritis • 15 Sep 2020
2:00
AL amyloidosis: Hot topics from ISA 2020
Vaishali Sanchorawala • 15 Sep 2020
5:43
Optimism for amyloidosis therapy
Joel Buxbaum • 3 Sep 2020

Therapy Updates

View all
6:29
Amyloid disease: aiming for a cure
Giampaolo Merlini • 1 Sep 2020
3:19
Supportive care in AL amyloidosis
Joan Bladé • 2 Sep 2020
6:10
Auto-HSCT in AL amyloidosis
Eli Muchtar • 9 Sep 2020
2:45
Burning questions: ASCT in AL amyloidosis
Vaishali Sanchorawala • 15 Sep 2020

Diagnosis

View all
2:20
New prognostic markers in AL amyloidosis
Efstathios Kastritis • 15 Sep 2020
4:10
MRD using multi-parametric flow cytometry in AL amyloidosis
Andrew Staron • 10 Sep 2020
1:19
AL Amyloidosis: MRD negativity
Nelson Leung • 3 Sep 2020

AA Amyloidosis

View all
0:52
Tocilizumab for AA amyloidosis
Luis Quintana • 4 Sep 2020
1:04
AA amyloidosis management
Luis Quintana • 10 Sep 2020

ATTR Amyloidosis

View all
10:09
ISA 2020: continuing the amyloidosis conversation
Joan Bladé • 2 Sep 2020
15:21
Genetic signatures & hereditary ATTR amyloidosis
Joel Buxbaum • 3 Sep 2020
The content of VJHemOnc is intended for healthcare professionals